Morgan Stanley reports today. The options market is leaning defensive. Short sellers, meanwhile, have been quietly exiting for weeks.
These two signals point in opposite directions — and together they tell a nuanced pre-earnings story.
The put/call ratio hit 1.47 on May 13. That's a z-score of 2.23 against a 20-day mean of 1.42. Traders are paying up for downside protection — not a panic signal, but a meaningful skew heading into today's print.
Context matters here. The 52-week PCR range runs from 1.10 to 1.62. At 1.47, the market is cautious but not at the extremes. The last two earnings prints for MS moved +2.2% and +4.6% on day one. Puts may simply be the rational hedge against a surprise miss.
SI sits at just 0.86% of free float — below the threshold where short positioning is a primary story. But the direction is striking. Shares short have fallen 21.6% over the past month. From mid-April highs near 17.9 million shares, the position has contracted to 13.8 million.
That's not a squeeze dynamic. It's systematic de-risking. Shorts reduced exposure ahead of an event they likely didn't want to be caught in.
The cost to borrow climbed to 0.41% — up 95% over the past week. That's an unusual combination: fewer short positions but a tighter lending market. Availability has tightened as the remaining short base holds firm and new hedgers seek protection. At 0.41%, the CTB remains low in absolute terms, but the pace of the move is notable for a large-cap investment bank.
Seven firms raised their price targets following the Q1 print on April 16. The mean target now stands at $203. With MS closing at $193.83 on May 13, implied upside is modest at roughly 5%.
Citigroup raised its target to $194 on May 8 — barely above where the stock was trading. Barclays sits more bullish at $230. The consensus is constructive but not stretched.
T. Rowe Price added 3.4 million shares in Q1. BlackRock added 1.6 million. Both are recent increases among the institutional holder base.
See the live data behind this article on ORTEX.
Open MS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
